Biotech Values

[spartex]

Repros executives get pay hike
Houston Business Journal - 3:36 PM CST Friday

The board of directors of Repros Therapeutics Inc. have approved salary increases for CEO Joseph Podolski and Louis Ploth, the firm's chief financial officer, effective Jan. 1.

According to a Securities and Exchange Commission filing submitted Friday, Podolski, also president of The Woodlands-based Repros (NASDAQ: RPRX) will see his annual salary increase by 7 percent to $354,000. Ploth, also vice president of business development, will see his salary bumped to $224,000.

In addition, Podolski and Ploth received options to purchase as many as 50,000 shares and 20,000 shares of the biopharmaceutical firm, respectively, at $12.26 over three years, based on the Jan. 8 closing price, the date of grant.

Trading volume on Repros shares moved slightly higher than normal Friday, boosting the shares by more than 4 percent, or 55 cents, to close at $12.79

http://www.bizjournals.com/houston/stories/2007/01/08/daily56.html?f=et63&hbx=e_du